Event Cancelled

We are sorry to report the sudden death of Dan Best. As a result, the Employee Benefits Leadership Forum on November 15 has been cancelled. We appreciate your interest in this important topic and willingness to engage with other industry leaders on the future of drug pricing. Our deepest sympathies go out to Dan’s family, friends, and colleagues at this difficult time.

Thursday, November 15

11:00 a.m. – 12:30 p.m.

We invite you to learn about and contribute to the President’s initiatives for reducing the nation’s prescription drug costs. This complimentary, invitation-only event for select corporate benefits executives will be a live interactive videoconference hosted at a few Thompson Hine offices.

F E A T U R E D   G U E S T

Daniel M. Best

Senior Advisor to the Secretary, Drug Policy Reform
U.S. Department of Health and Human Services

Featuring top Trump administration official Dan Best, you will learn firsthand about the administration’s blueprint to lower drug prices for all Americans, as well as pose questions and provide feedback to help shape the approach. The government is hearing from pharma, health systems and insurers. Now is the time for your voice to be heard.

As with our typical Roundtable gatherings, there will also be an opportunity to share and discuss perspectives among participants at each meeting location.

If you have questions about the event or think of something else you would like to ask Dan Best after making your reservation, feel free to contact Tom Hitchcock at thitchcock@chelkogroup.com

About Daniel Best

The Senior Advisor to the Secretary for Drug Policy Reform, Mr. Best joined HHS in April 2018 from CVS Caremark Corporation, where he worked for the last six years, most recently as Corporate Vice President of Industry Relations for its Medicare Part D business. In that capacity, he devised and executed on strategies that supported new and existing client bid position to improve their competitiveness in the Medicare Part D Space. Prior to working at CVS, Dan spent three years at Universal American, startup MemberHealth, and 12 years at Pfizer Pharmaceuticals. He holds a degree in Accounting from the University of Dayton.

Read the Blueprint

If you haven’t already, consider reading American Patients First: The Trump Administration Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs.

Download a Copy